CH593285A5 - - Google Patents

Info

Publication number
CH593285A5
CH593285A5 CH164973A CH164973A CH593285A5 CH 593285 A5 CH593285 A5 CH 593285A5 CH 164973 A CH164973 A CH 164973A CH 164973 A CH164973 A CH 164973A CH 593285 A5 CH593285 A5 CH 593285A5
Authority
CH
Switzerland
Application number
CH164973A
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL7201675A external-priority patent/NL7201675A/xx
Priority claimed from NL7215366A external-priority patent/NL7215366A/xx
Application filed by Philips Nv filed Critical Philips Nv
Publication of CH593285A5 publication Critical patent/CH593285A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH164973A 1972-02-09 1973-02-06 CH593285A5 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7201675A NL7201675A (fi) 1972-02-09 1972-02-09
NL7215366A NL7215366A (en) 1972-11-14 1972-11-14 P-dioxino(2,3-g)quinolines - diuretics, saluretics and hypotensives

Publications (1)

Publication Number Publication Date
CH593285A5 true CH593285A5 (fi) 1977-11-30

Family

ID=26644729

Family Applications (1)

Application Number Title Priority Date Filing Date
CH164973A CH593285A5 (fi) 1972-02-09 1973-02-06

Country Status (16)

Country Link
US (1) US3865832A (fi)
JP (1) JPS5727112B2 (fi)
AR (1) AR211510A1 (fi)
AT (1) AT323740B (fi)
BE (1) BE795265A (fi)
CA (1) CA1000279A (fi)
CH (1) CH593285A5 (fi)
DE (1) DE2303496A1 (fi)
DK (1) DK138120B (fi)
ES (1) ES411374A1 (fi)
FI (1) FI55847C (fi)
FR (1) FR2181708B1 (fi)
GB (1) GB1366834A (fi)
IL (1) IL41471A (fi)
PH (1) PH14448A (fi)
SE (1) SE416467B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036962A (en) * 1974-08-12 1977-07-19 E. I. Du Pont De Nemours And Co. 6,7-Methylenedioxy-1-(2,2,2-trifluoroethyl)-4(1H)-quinolone-3-carboxylic acid and its salts and esters
US4179506A (en) * 1978-11-13 1979-12-18 Warner-Lambert Company New pyridobenzodioxin compounds and methods for their production
FR2846327B1 (fr) * 2002-10-25 2006-03-24 Merck Sante Sas Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
JP5755217B2 (ja) * 2009-03-30 2015-07-29 トランステック・ファーマ,エルエルシー 置換アゾアントラセン誘導体、その医薬組成物とその使用の方法
CN113717185B (zh) * 2021-08-19 2023-04-11 云南省烟草农业科学研究院 雪茄烟根茎中一种具有抗菌活性的喹啉生物碱化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178348A (en) * 1961-02-08 1965-04-13 Norwich Pharma Co Hypotensive quinolines
GB1076828A (en) * 1963-12-12 1967-07-26 Warner Lambert Pharmaceutical Methylenedioxy quinoline derivatives
DE1908548A1 (de) * 1968-02-29 1970-11-05 Warner Lambert Co Chinolinderivate
CA942310A (en) * 1969-07-09 1974-02-19 Mitsuo Nakashita Preparation of n-substituted 6,7-methylenedioxy-4-quinolone derivatives
DE2030899A1 (de) * 1970-06-18 1971-12-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen Chinolincarbonsäurederivate

Also Published As

Publication number Publication date
JPS5727112B2 (fi) 1982-06-08
FI55847B (fi) 1979-06-29
AT323740B (de) 1975-07-25
FI55847C (fi) 1979-10-10
IL41471A0 (en) 1973-04-30
PH14448A (en) 1981-07-23
AR211510A1 (es) 1978-01-30
DE2303496A1 (de) 1973-08-23
SE416467B (sv) 1981-01-05
DK138120B (da) 1978-07-17
GB1366834A (en) 1974-09-11
ES411374A1 (es) 1976-07-01
DK138120C (fi) 1978-12-04
FR2181708B1 (fi) 1975-10-10
JPS4886896A (fi) 1973-11-15
IL41471A (en) 1975-12-31
BE795265A (fr) 1973-08-09
US3865832A (en) 1975-02-11
FR2181708A1 (fi) 1973-12-07
CA1000279A (en) 1976-11-23

Similar Documents

Publication Publication Date Title
JPS5218097B2 (fi)
FR2194328A5 (fi)
JPS5037157B2 (fi)
JPS5038413B2 (fi)
JPS4974212A (fi)
JPS5218902Y2 (fi)
JPS5211123Y2 (fi)
JPS4928761Y1 (fi)
JPS4980347A (fi)
FR2169307A1 (fi)
FR2210038A1 (fi)
JPS4911079A (fi)
CH590827A5 (fi)
BG18499A1 (fi)
CH322372A4 (fi)
CH1809873A4 (fi)
CH1668773A4 (fi)
BG18292A1 (fi)
CH1486873A4 (fi)
CH564321A5 (fi)
CH602631A5 (fi)
BG19428A1 (fi)
CH601157A5 (fi)
CH594595A5 (fi)
CH578587A5 (fi)

Legal Events

Date Code Title Description
PUE Assignment

Owner name: DUPHAR INTERNATIONAL RESEARCH B.V.

PL Patent ceased